In general, the personalized E-DES models displayed good agreement with the data both when calibrated on plasma glucose as well as CGM glucose in a wide range of glucose and insulin responses after an OGTT in individuals with overweight or obesity. The gene discussed is INS; the disease is obesity disorder.